PureTech Health PLC (NAS:PRTC)
$ 24.53 -1.37 (-5.29%) Market Cap: 598.64 Mil Enterprise Value: 330.27 Mil PE Ratio: 0 PB Ratio: 1.34 GF Score: 53/100

PureTech Health PLC at UBS Global Healthcare Conference Transcript

May 24, 2022 / 02:45PM GMT
Release Date Price: $23.19 (+0.17%)
Gavin Fernandez

Good morning, everyone. Thank you all for attending, and thank you for all those at home watching live. Hope you all enjoyed your breakfast and all that, and the speakers so far.

My name is Gavin Fernandez, and I'm an analyst on the UBS Healthcare team. I'm excited to introduce PureTech, a biotech company that develops and commercializes therapies for conditions with limited or no existing treatment options. Following this presentation, we will have a moderated Q&A session. But for now, PureTech. And George, thank you. Go ahead.

George Farmer
PureTech Health plc - CFO

Great. Thanks for the introduction, Gavin. I'm George Farmer, Chief Financial Officer of PureTech. I'd like to thank the UBS for involving us in this conference today and for the opportunity to present, and I welcome everyone in the audience and on the webcast.

During this presentation, we will be making some forward-looking statements, and I ask that you refer to our SEC filings available at sec.gov for a discussion of potential risks and uncertainties. All

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot